Dec. 2, 2021 - 10:51 - Pfizer CEO Albert Bourla discusses the company's experimental antiviral pill for COVID-19, which researchers found cut rates of hospitalization and death by nearly 90% in high-risk adults.
For video troubleshooting and help click here.
